Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma-Reference-Cited by-同舟云学术

Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma

Published:2008-10 Issue:10 Volume:30 Page:1318-1324
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Preuss Simon Florian,Weinell Antje,Molitor Markus,Semrau Robert,Stenner Markus,Drebber Uta,Wedemeyer Inga,Hoffmann Thomas K.,Guntinas-Lichius Orlando,Klussmann Jens Peter

Publisher

Wiley

Subject

Otorhinolaryngology

Reference40 articles.

1. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas;Santini;Head Neck,1991

2. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer;Dassonville;J Clin Oncol,1993

3. Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck;Reuter;Br J Cancer,2007

4. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

5. Survivin study: an update of “what is the next wave”?;Li;J Cell Physiol,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression patterns of uPAR, TF and EGFR and their potential as targets for molecular imaging in oropharyngeal squamous cell carcinoma;Oncology Reports;2022-06-30

2. Anti‐oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient‐derived tumor xenograft model;Head & Neck;2018-12-10

3. The cost of oropharyngeal cancer in England: A retrospective hospital data analysis;Clinical Otolaryngology;2017-08-14

4. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma;Clinical Otolaryngology;2017-08-14

5. Molecular Patterns and Biology of HPV-Associated HNSCC;HPV Infection in Head and Neck Cancer;2016-10-04